---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-012986"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2022-07-25T23:59:59+00:00"
generated_at: "2026-06-24T09:14:11.933597+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medpace reports Q2 2022 revenue $351.2M (+26.2% YoY), diluted EPS $1.46 vs $1.06

## Summary
- Revenue $351.2M, up 26.2% YoY; constant currency organic growth 27.7%.
- GAAP net income $49.4M ($1.46 diluted EPS) vs $39.9M ($1.06) YoY.
- Net new business awards $450.6M (book-to-bill 1.28x), up 16.3% YoY.
- Backlog $2.2B, up 24.4% from $1.7B YoY.
- EBITDA $68.1M (19.4% margin), up 42% YoY from $47.9M (17.2%).

## SEC filing metadata
- accession: 0000950170-22-012986
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2022-07-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000095017022012986/0000950170-22-012986-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000095017022012986/medp-20220725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-012986
- JSON: https://secwatch.observer/filing/0000950170-22-012986.json
- Plain text: https://secwatch.observer/filing/0000950170-22-012986.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.